Lexicon Pharmaceuticals logo

Lexicon Pharmaceuticals Share Price Today

(NASDAQ: LXRX)

Lexicon Pharmaceuticals share price is $0.34 & ₹29.57 as on 6 Mar 2025, 2.30 'hrs' IST

$0.34

▲

0.01

(3.45%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Lexicon Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Lexicon Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Lexicon Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Lexicon Pharmaceuticals share price movements

  • Today's Low: $0.31
    Today's High: $0.34

    Day's Volatility :11.09%

  • 52 Weeks Low: $0.28
    52 Weeks High: $2.83

    52 Weeks Volatility :89.98%

Lexicon Pharmaceuticals (LXRX) Returns

PeriodLexicon Pharmaceuticals, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-50.03%
2.1%
0.0%
6 Months
-79.95%
-4.1%
0.0%
1 Year
-85.17%
2.2%
0.0%
3 Years
-84.68%
11.8%
-11.6%

Lexicon Pharmaceuticals (LXRX) Key Statistics

in dollars & INR

Previous Close
$0.3248
Open
$0.324
Today's High
$0.3435
Today's Low
$0.3054
Market Capitalization
$105.8M
Today's Volume
$4.1M
52 Week High
$2.8291
52 Week Low
$0.2836
Revenue TTM
$5.2M
EBITDA
$-210.6M
Earnings Per Share (EPS)
$-0.74
Profit Margin
0.0%
Quarterly Earnings Growth YOY
-0.63%
Return On Equity TTM
-136.09%

How to invest in Lexicon Pharmaceuticals Stock (LXRX) from India?

It is very easy for Indian residents to invest directly in Lexicon Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lexicon Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lexicon Pharmaceuticals or LXRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lexicon Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lexicon Pharmaceuticals shares which would translate to 2.558 fractional shares of Lexicon Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Lexicon Pharmaceuticals, in just a few clicks!

Returns in Lexicon Pharmaceuticals (LXRX) for Indian investors in Rupees

The Lexicon Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lexicon Pharmaceuticals investment value today

Current value as on today

₹20,488

Returns

₹79,512

(-79.51%)

Returns from Lexicon Pharmaceuticals Stock

₹84,475 (-84.47%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Lexicon Pharmaceuticals (LXRX)

2%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Lexicon Pharmaceuticals Stock from India on INDmoney has increased by 2% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Lexicon Pharmaceuticals

  • Artal Group S A

    37.67%

  • FMR Inc

    14.38%

  • Siren, L.L.C.

    10.77%

  • BlackRock Inc

    2.86%

  • Vanguard Group Inc

    2.73%

  • Point72 Asset Management, L.P.

    2.49%

Analyst Recommendation on Lexicon Pharmaceuticals

Buy

    72%Buy

    27%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Lexicon Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
7
7
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Lexicon Pharmaceuticals Stock (LXRX)

What analysts predicted

Upside of 958.82%

Target:

$3.60

Current:

$0.34

Insights on Lexicon Pharmaceuticals Stock (Ticker Symbol: LXRX)

  • Price Movement

    In the last 7 days, LXRX stock has moved down by -54.0%

  • Increasing Revenue

    Revenue is up for the last 5 quarters, 162.0K → 1.75M (in $), with an average increase of 38.0% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -48.24M → -64.81M (in $), with an average decrease of 10.7% per quarter

  • LXRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 147.9%

  • LXRX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 132.5%

  • Price to Sales

    ForLXRX every $1 of sales, investors are willing to pay $18.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

LXRX Lexicon Pharmaceuticals Financials in INR & Dollars

FY18Y/Y Change
Revenue
$63.2M
↓ 30.03%
Net Income
$-120.5M
↓ 6.59%
Net Profit Margin
-190.71%
↓ 47.85%
FY19Y/Y Change
Revenue
$322.1M
↑ 409.54%
Net Income
$130.1M
↓ 207.95%
Net Profit Margin
40.4%
↑ 231.11%
FY20Y/Y Change
Revenue
$24.0M
↓ 92.55%
Net Income
$-70.2M
↓ 153.93%
Net Profit Margin
-292.49%
↓ 332.89%
FY21Y/Y Change
Revenue
$298.0K
↓ 98.76%
Net Income
$-88.3M
↑ 25.77%
Net Profit Margin
-29.6K%
↓ 29327.64%
FY22Y/Y Change
Revenue
$139.0K
↓ 53.36%
Net Income
$-103.1M
↑ 16.84%
Net Profit Margin
-74.2K%
↓ 44572.68%
FY23Y/Y Change
Revenue
$1.2M
↑ 766.19%
Net Income
$-177.1M
↑ 71.75%
Net Profit Margin
-14.7K%
↑ 59481.93%
Q2 FY23Q/Q Change
Revenue
$317.0K
↑ 1220.83%
Net Income
$-44.9M
↑ 45.3%
Net Profit Margin
-14.2K%
↑ 114605.53%
Q3 FY23Q/Q Change
Revenue
$162.0K
↓ 48.9%
Net Income
$-50.5M
↑ 12.52%
Net Profit Margin
-31.2K%
↓ 17022.97%
Q4 FY23Q/Q Change
Revenue
$702.0K
↑ 333.33%
Net Income
$-48.2M
↓ 4.51%
Net Profit Margin
-6.9K%
↑ 24315.91%
Q1 FY24Q/Q Change
Revenue
$1.1M
↑ 60.97%
Net Income
$-48.4M
↑ 0.32%
Net Profit Margin
-4.3K%
↑ 2589.44%
Q2 FY24Q/Q Change
Revenue
$1.6M
↑ 45.75%
Net Income
$-53.4M
↑ 10.4%
Net Profit Margin
-3.2K%
↑ 1038.9%
Q3 FY24Q/Q Change
Revenue
$1.8M
↑ 6.25%
Net Income
$-64.8M
↑ 21.3%
Net Profit Margin
-3.7K%
↓ 459.47%
FY18Y/Y Change
Profit
$60.7M
↓ 31.34%
FY19Y/Y Change
Profit
$318.8M
↑ 425.12%
FY20Y/Y Change
Profit
$22.1M
↓ 93.08%
FY21Y/Y Change
Profit
$-54.7M
↓ 348.11%
FY22Y/Y Change
Profit
$-288.0K
↓ 99.47%
FY23Y/Y Change
Profit
$1.1M
↓ 488.54%
Q2 FY23Q/Q Change
Profit
$309.0K
↓ 451.14%
Q3 FY23Q/Q Change
Profit
$155.0K
↓ 49.84%
Q4 FY23Q/Q Change
Profit
$485.0K
↑ 212.9%
Q1 FY24Q/Q Change
Profit
$955.0K
↑ 96.91%
Q2 FY24Q/Q Change
Profit
$1.5M
↑ 55.08%
Q3 FY24Q/Q Change
Profit
$1.7M
↑ 13.37%
FY18Y/Y Change
Operating Cash Flow
$-148.6M
↓ 19.84%
Investing Cash Flow
$169.6M
↑ 235.65%
Financing Cash Flow
$-2.2M
↓ 101.5%
FY19Y/Y Change
Operating Cash Flow
$113.8M
↓ 176.58%
Investing Cash Flow
$-155.9M
↓ 191.91%
Financing Cash Flow
$-2.2M
↓ 0.8%
FY20Y/Y Change
Operating Cash Flow
$-143.0M
↓ 225.62%
Investing Cash Flow
$380.8M
↓ 344.3%
Financing Cash Flow
$-147.6M
↑ 6532.35%
FY21Y/Y Change
Operating Cash Flow
$-87.0M
↓ 39.14%
Investing Cash Flow
$2.1M
↓ 99.45%
Financing Cash Flow
$22.7M
↓ 115.38%
FY22Y/Y Change
Operating Cash Flow
$-88.9M
↑ 2.11%
Investing Cash Flow
$-71.1M
↓ 3468.63%
Financing Cash Flow
$142.2M
↑ 526.22%
Q2 FY23Q/Q Change
Operating Cash Flow
$-38.1M
↑ 20.57%
Investing Cash Flow
$-74.6M
↓ 716.95%
Financing Cash Flow
$189.0M
↓ 23036.29%

Lexicon Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Lexicon Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Lexicon Pharmaceuticals (LXRX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Lexicon Pharmaceuticals, Inc. logo
Lexicon Pharmaceuticals, Inc.
-57.27%
-79.95%
-85.17%
-84.68%
-85.3%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
Beone Medicines Ltd
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Lexicon Pharmaceuticals, Inc. logo
Lexicon Pharmaceuticals, Inc.
NA
NA
-0.14
-0.69
-1.36
-0.44
NA
0.49
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
Beone Medicines Ltd
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Lexicon Pharmaceuticals, Inc. logo
Lexicon Pharmaceuticals, Inc.
Buy
$105.8M
-85.3%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
Beone Medicines Ltd
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
Buy
$31.5B
120.93%
NA
-12.37%

About Lexicon Pharmaceuticals

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.
Organization
Lexicon Pharmaceuticals
Employees
285
CEO
Dr. Michael Exton Ph.D.
Industry
Health Technology

Management People of Lexicon Pharmaceuticals

NameTitle
Mr. Brian T. Crum
Senior VP, General Counsel & Secretary
Dr. Alan J. Main Ph.D.
Executive Vice President of Innovation & Chemical Sciences
Dr. Craig B. Granowitz M.D., Ph.D.
Senior VP & Chief Medical Officer
Dr. Michael Exton Ph.D.
CEO & Director
Mr. Scott M. Coiante
CFO & Senior VP
Ms. Kristen L. Alexander
Vice President of Finance & Accounting
Ms. Lisa M. DeFrancesco
Vice President of Investor Relations & Corporate Communications
Mr. Dixon Terry
Vice President of Compliance
Ms. Carrie Siragusa
Vice President of Marketing
Ms. Desiree Gendron
Vice President of Sales & Training

Important FAQs about investing in LXRX Stock from India :

What is Lexicon Pharmaceuticals share price today?

Lexicon Pharmaceuticals share price today stands at $0.34, Open: $0.32 ; Previous Close: $0.32 ; High: $0.34 ; Low: $0.31 ; 52 Week High: $2.83 ; 52 Week Low: $0.28.

The stock opens at $0.32, after a previous close of $0.32. The stock reached a daily high of $0.34 and a low of $0.31, with a 52-week high of $2.83 and a 52-week low of $0.28.

Can Indians buy Lexicon Pharmaceuticals shares?

Yes, Indians can invest in the Lexicon Pharmaceuticals (LXRX) from India.

With INDmoney, you can buy Lexicon Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Lexicon Pharmaceuticals at zero transaction cost.

How can I buy Lexicon Pharmaceuticals shares from India?

It is very easy to buy Lexicon Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lexicon Pharmaceuticals (LXRX) be purchased?

Yes, you can buy fractional shares of Lexicon Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Lexicon Pharmaceuticals stocks?

To start investing in Lexicon Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Lexicon Pharmaceuticals Stock (LXRX)?

Today’s highest price of Lexicon Pharmaceuticals (LXRX) is $0.34.

Today’s lowest price of Lexicon Pharmaceuticals (LXRX) is $0.31.

What is today's market capitalisation of Lexicon Pharmaceuticals?

Today's market capitalisation of Lexicon Pharmaceuticals LXRX is 105.8M

What is the 52 Week High and Low Range of Lexicon Pharmaceuticals Stock (LXRX)?

  • 52 Week High

    $2.83

  • 52 Week Low

    $0.28

What are the historical returns of Lexicon Pharmaceuticals (LXRX)?

  • 1 Month Returns

    -57.27%

  • 3 Months Returns

    -79.95%

  • 1 Year Returns

    -85.17%

  • 5 Years Returns

    -85.3%

Who is the Chief Executive Officer (CEO) of Lexicon Pharmaceuticals ?

Dr. Michael Exton Ph.D. is the current Chief Executive Officer (CEO) of Lexicon Pharmaceuticals.